Profits from the first day of sales will be donated to the Paramus Children’s Health Foundation

New Jersey Innovation Institute’s pioneering cell and gene therapy center is advancing this investigational curative therapy by leveraging lab-grown virus-specific t-lymphocytes to recognize and destroy COVID-19-infected cells.

Kevin Conlin’s retirement comes a year after he stepped out of his CEO role in February 2020 and moved into the role of executive chairman in April 2020.  Horizon’s Board of Directors elected Todd Brown, who has served on Horizon’s Board since 2012 and as its lead director since 2018, as the company’s next chairman.

As of March 15, there were 3 million vaccine doses administered, of which 1 million were the second shots required from Pfizer and Moderna. State health officials are aiming to have 4.7 million adults fully vaccinated by some point in June.

A recent white paper by the Health Action Council and UnitedHealthcare finds companies that implement deliberate strategies around their employees’ most common chronic health conditions may improve overall employee health and achieve cost-savings over the long-term.

The partnership expands advanced cancer care to Philadelphia, Montgomery and Bucks counties allowing those residents to stay close to home and have convenient access to proven cancer treatment protocols, cancer experts, clinical research and patient support and education resources.

In addition to fundraising for the system’s priorities, the organization will deliver cost savings through the centralization of operations and office space

The CEO of University Hospital in Newark, who witnessed some of the pandemic's worst manifestations, reflects on the past year and discusses some of the recent developments that are providing hope after the long lockdown.

The addition of new doses, plus the rollout of the two-dose Pfizer and Moderna vaccines, would put the number of available vaccines by the summer well beyond the estimated 331 million people living in the United States.

The ranking publication analyzes how well states serve their residents in a variety of ways, as the Graden State saw some highs as well as some lows.

Cristine Delnevo will be one of nine voting members on the team advising the FDA on tobacco product regulation through the end of a four-year appointment.

The Kenilworth-based drug maker says data on its drug molnupiravir in both outpatient and hospital settings shows progress in reducing the virus level.